385 related articles for article (PubMed ID: 14699046)
1. Entropic switch regulates myristate exposure in the HIV-1 matrix protein.
Tang C; Loeliger E; Luncsford P; Kinde I; Beckett D; Summers MF
Proc Natl Acad Sci U S A; 2004 Jan; 101(2):517-22. PubMed ID: 14699046
[TBL] [Abstract][Full Text] [Related]
2. Myristate exposure in the human immunodeficiency virus type 1 matrix protein is modulated by pH.
Fledderman EL; Fujii K; Ghanam RH; Waki K; Prevelige PE; Freed EO; Saad JS
Biochemistry; 2010 Nov; 49(44):9551-62. PubMed ID: 20886905
[TBL] [Abstract][Full Text] [Related]
3. Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation.
Wu Z; Alexandratos J; Ericksen B; Lubkowski J; Gallo RC; Lu W
Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11587-92. PubMed ID: 15280532
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly.
Saad JS; Miller J; Tai J; Kim A; Ghanam RH; Summers MF
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11364-9. PubMed ID: 16840558
[TBL] [Abstract][Full Text] [Related]
5. Point mutations in the HIV-1 matrix protein turn off the myristyl switch.
Saad JS; Loeliger E; Luncsford P; Liriano M; Tai J; Kim A; Miller J; Joshi A; Freed EO; Summers MF
J Mol Biol; 2007 Feb; 366(2):574-85. PubMed ID: 17188710
[TBL] [Abstract][Full Text] [Related]
6. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.
Ono A; Freed EO
J Virol; 1999 May; 73(5):4136-44. PubMed ID: 10196310
[TBL] [Abstract][Full Text] [Related]
7. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism.
Spearman P; Horton R; Ratner L; Kuli-Zade I
J Virol; 1997 Sep; 71(9):6582-92. PubMed ID: 9261380
[TBL] [Abstract][Full Text] [Related]
8. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein.
Zhou W; Resh MD
J Virol; 1996 Dec; 70(12):8540-8. PubMed ID: 8970978
[TBL] [Abstract][Full Text] [Related]
9. Mutations that mimic phosphorylation of the HIV-1 matrix protein do not perturb the myristyl switch.
Saad JS; Kim A; Ghanam RH; Dalton AK; Vogt VM; Wu Z; Lu W; Summers MF
Protein Sci; 2007 Aug; 16(8):1793-7. PubMed ID: 17656588
[TBL] [Abstract][Full Text] [Related]
10. Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.
Paillart JC; Göttlinger HG
J Virol; 1999 Apr; 73(4):2604-12. PubMed ID: 10074105
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
12. Role of the HIV-1 Matrix Protein in Gag Intracellular Trafficking and Targeting to the Plasma Membrane for Virus Assembly.
Ghanam RH; Samal AB; Fernandez TF; Saad JS
Front Microbiol; 2012; 3():55. PubMed ID: 22363329
[TBL] [Abstract][Full Text] [Related]
13. Cooperative Membrane Binding of HIV-1 Matrix Proteins.
Banerjee P; Monje-Galvan V; Voth GA
J Phys Chem B; 2024 Mar; 128(11):2595-2606. PubMed ID: 38477117
[TBL] [Abstract][Full Text] [Related]
14. NMR, biophysical, and biochemical studies reveal the minimal Calmodulin binding domain of the HIV-1 matrix protein.
Samal AB; Ghanam RH; Fernandez TF; Monroe EB; Saad JS
J Biol Chem; 2011 Sep; 286(38):33533-43. PubMed ID: 21799007
[TBL] [Abstract][Full Text] [Related]
15. Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein.
Tang C; Ndassa Y; Summers MF
Nat Struct Biol; 2002 Jul; 9(7):537-43. PubMed ID: 12032547
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus type 1 matrix inhibits and confers cooperativity on gag precursor-membrane interactions.
Perez-Caballero D; Hatziioannou T; Martin-Serrano J; Bieniasz PD
J Virol; 2004 Sep; 78(17):9560-3. PubMed ID: 15308748
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Matrix Protein Interactions with tRNA: Implications for Membrane Targeting.
Gaines CR; Tkacik E; Rivera-Oven A; Somani P; Achimovich A; Alabi T; Zhu A; Getachew N; Yang AL; McDonough M; Hawkins T; Spadaro Z; Summers MF
J Mol Biol; 2018 Jul; 430(14):2113-2127. PubMed ID: 29752967
[TBL] [Abstract][Full Text] [Related]
18. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.
Ono A; Orenstein JM; Freed EO
J Virol; 2000 Mar; 74(6):2855-66. PubMed ID: 10684302
[TBL] [Abstract][Full Text] [Related]
19. Membrane-induced alterations in HIV-1 Gag and matrix protein-protein interactions.
Scarlata S; Ehrlich LS; Carter CA
J Mol Biol; 1998 Mar; 277(2):161-9. PubMed ID: 9514761
[TBL] [Abstract][Full Text] [Related]
20. Influence of MA internal sequences, but not of the myristylated N-terminus sequence, on the budding site of HIV-1 Gag protein.
Gallina A; Mantoan G; Rindi G; Milanesi G
Biochem Biophys Res Commun; 1994 Nov; 204(3):1031-8. PubMed ID: 7980574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
